These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24260137)

  • 1. Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009.
    Hanna DB; Buchacz K; Gebo KA; Hessol NA; Horberg MA; Jacobson LP; Kirk GD; Kitahata MM; Korthuis PT; Moore RD; Napravnik S; Patel P; Silverberg MJ; Sterling TR; Willig JH; Collier A; Samji H; Thorne JE; Althoff KN; Martin JN; Rodriguez B; Stuart EA; Gange SJ;
    PLoS One; 2013; 8(11):e78952. PubMed ID: 24260137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The AIDS drug assistance programs and coverage of HIV-related medications.
    Smith SR; Buchanan RJ
    Ann Pharmacother; 2001 Feb; 35(2):155-66. PubMed ID: 11215833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing resource allocation in United States AIDS drug assistance programs.
    Linas BP; Zheng H; Losina E; Rockwell A; Walensky RP; Cranston K; Freedberg KA
    Clin Infect Dis; 2006 Nov; 43(10):1357-64. PubMed ID: 17051505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009.
    Hanna DB; Buchacz K; Gebo KA; Hessol NA; Horberg MA; Jacobson LP; Kirk GD; Kitahata MM; Korthuis PT; Moore RD; Napravnik S; Patel P; Silverberg MJ; Sterling TR; Willig JH; Lau B; Althoff KN; Crane HM; Collier AC; Samji H; Thorne JE; Gill MJ; Klein MB; Martin JN; Rodriguez B; Rourke SB; Gange SJ;
    Clin Infect Dis; 2013 Apr; 56(8):1174-82. PubMed ID: 23315317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eligibility policies for the state AIDS drug assistance programs.
    Buchanan RJ; Chakravorty BJ; Smith SR
    Soc Work Health Care; 2001; 32(3):81-104. PubMed ID: 11358274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State AIDS Drug Assistance Programs: equity and efficiency in an era of rapidly changing treatment standards.
    Johri M; David Paltiel A; Goldie SJ; Freedberg KA
    Med Care; 2002 May; 40(5):429-41. PubMed ID: 11961477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinton seeks $65 million for States' AIDS drug programs.
    AIDS Policy Law; 1996 Aug; 11(14):3. PubMed ID: 11363679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current challenges to the United states' AIDS drug assistance program and possible implications of the affordable care act.
    McManus KA; Engelhard CL; Dillingham R
    AIDS Res Treat; 2013; 2013():350169. PubMed ID: 23573418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State variation in AIDS drug assistance program prescription drug coverage for modifiable cardiovascular risk factors.
    Blackstock OJ; Wang KH; Fiellin DA
    J Gen Intern Med; 2011 Dec; 26(12):1426-33. PubMed ID: 21837376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAP faces financial abyss. AIDS Drug Assistance Programs.
    Link D
    GMHC Treat Issues; 1996 Feb; 10(2):11-6. PubMed ID: 11363381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving outcomes in state AIDS drug assistance programs.
    Linas BP; Losina E; Rockwell A; Walensky RP; Cranston K; Freedberg KA
    J Acquir Immune Defic Syndr; 2009 Aug; 51(5):513-21. PubMed ID: 19561518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the need to reform the US AIDS Drug Assistance Program.
    Whigham MR
    J Int Assoc Physicians AIDS Care; 1998 Jan; 4(1):39-40. PubMed ID: 11365032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. $90.2 million budget shortfall projected for ADAPS.
    Body Posit; 1999 Aug; 12(8):39. PubMed ID: 11367071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chances dim for fiscal '97 boost in AIDS drug funds.
    AIDS Policy Law; 1997 Jun; 12(11):1, 10. PubMed ID: 11364383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes and factors associated with survival of patients with HIV/AIDS initiating antiretroviral treatment in Liangshan Prefecture, southwest of China: A retrospective cohort study from 2005 to 2013.
    Zhang G; Gong Y; Wang Q; Deng L; Zhang S; Liao Q; Yu G; Wang K; Wang J; Ye S; Liu Z
    Medicine (Baltimore); 2016 Jul; 95(27):e3969. PubMed ID: 27399071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. California increases ADAP funding; SFAF now an ADAP site.
    Highleyman L
    BETA; 1998 Oct; ():6. PubMed ID: 11365995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinton's ADAP proposal seen as a 'starting point'.
    AIDS Policy Law; 1998 Jan; 13(1):1, 12. PubMed ID: 11364953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy.
    Scott Sutton S; Magagnoli J; Hardin JW
    Pharmacotherapy; 2016 Apr; 36(4):385-401. PubMed ID: 26923931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affordable Care Act Qualified Health Plan Coverage: Association With Improved HIV Viral Suppression for AIDS Drug Assistance Program Clients in a Medicaid Nonexpansion State.
    McManus KA; Rhodes A; Bailey S; Yerkes L; Engelhard CL; Ingersoll KS; Stukenborg GJ; Dillingham R
    Clin Infect Dis; 2016 Aug; 63(3):396-403. PubMed ID: 27143661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State implementation of the AIDS drug assistance programs.
    Buchanan RJ; Smith SR
    Health Care Financ Rev; 1998; 19(3):39-62. PubMed ID: 10345412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.